Multisystem Inflammatory Syndrome Following COVID-19: A Rare Presentation in Adults
Keywords:
COVID-19, multisystem inflammatory syndrome in children, myocarditisAbstract
Background: A growing number of reports from around the world has described a severe inflammatory syndrome in
children similar to Kawasaki’s disease. This syndrome has been named multisystem inflammatory syndrome in children
(MIS-C). There have been anecdotal reports of MIS-C-like illness in young adults in their early twenties as well. We present
the case of a healthy 33-year-old woman who developed coronavirus disease 2019 (COVID-19) with clinical characteristics
resembling MIS-C, a rare form of COVID-19 described primarily in children under 21 years of age. Case presentation: The
patient presented with abdominal pain, loose motions, difficulty in breathing since 3 days and fever since 1 day. She was
otherwise healthy, with no prior medical history. Her hospital course was notable for leukocytosis, bradycardia, acute heart
failure (myocarditis) and pulmonary edema. MIS-C like illness secondary to COVID-19 was suspected due to presentation
of myocarditis, bradyarrhythmia and pulmonary edema. She improved after giving IV steroids, diuretics, anticoagulation
and supportive care and was discharged on hospital Day 5. Conclusion: MIS-C like illness should be considered in adults
presenting with atypical clinical findings and concern for COVID-19. Further research is needed to support the role of IVIG
and aspirin in this patient population.
Downloads
Published
Issue
Section
License
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.
